Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-08-0626PMID 19174559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer

  2008cited by this paper
• RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53

  2008cited by this paper
• The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.

  2007cited by this paper
• WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors

  2007cited by this paper
• Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

  2007cited by this paper
• Detection of Human Papillomavirus Type 31-Neutralizing Antibodies from Naturally Infected Patients by an Assay Based on Intracellular Assembly of Luciferase-Expressing Pseudovirions

  2007cited by this paper
• Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.

  2006cited by this paper
• Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes

  2006cited by this paper
• Assembly of Human Papillomavirus Type‐16 Virus‐Like Particles: Multifactorial Study of Assembly and Competing Aggregation

  2006influential reference
• Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA

  2006cited by this paper
• A bi-functional siRNA construct induces RNA interference and also primes PCR amplification for its own quantification

  2005cited by this paper
• Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo

  2005cited by this paper
• Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo

  2005cited by this paper
• Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells

  2004cited by this paper
• Oral Administration with Papillomavirus Pseudovirus Encoding IL-2 Fully Restores Mucosal and Systemic Immune Responses to Vaccinations in Aged Mice1

  2004cited by this paper
• Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

  2004cited by this paper
• Epidemiologic classification of human papillomavirus types associated with cervical cancer.

  2003cited by this paper
• siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

  2003cited by this paper
• In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA.

  2003cited by this paper
• Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system.

  2003cited by this paper
• Detection of Neutralizing Antibodies against Human Papillomaviruses (HPV) by Inhibition of Gene Transfer Mediated by HPV Pseudovirions

  2002cited by this paper
• Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

  2002cited by this paper
• Papillomaviruses and cancer: from basic studies to clinical application

  2002influential reference
• Papillomavirus Pseudovirus: a Novel Vaccine To Induce Mucosal and Systemic Cytotoxic T-Lymphocyte Responses

  2001cited by this paper
• Globocan 2000 : cancer incidence, mortality and prevalence worldwide

  2001cited by this paper
• Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate

  2001cited by this paper
• Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

  2000cited by this paper
• Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene.

  2000cited by this paper
• Papillomavirus virus-like particles as anticancer vaccines.

  1999cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999influential reference
• Ras signalling and apoptosis.

  1998cited by this paper
• In vitro gene transfer using human papillomavirus-like particles.

  1998cited by this paper
• Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

  1996cited by this paper
• Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus

  1996cited by this paper
• E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.

  1996cited by this paper
• Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.

  1996cited by this paper
• Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells.

  1994cited by this paper
• Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells.

  1994cited by this paper
• Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles

  1993cited by this paper
• The biology of human papillomaviruses: from warts to cancer.

  1993cited by this paper
• The biology of human papillomaviruses: from warts to cancer.

  1993cited by this paper
• Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles

  1993cited by this paper
• The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes

  1989cited by this paper

• A Novel Approach of Antiviral Drugs Targeting Viral Genomes

  2022cites this paper
• Emergence of Oncogenic High-Risk Human Papillomavirus Types and Cervical Cancer

  2020cites this paper
• IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer

  2020cites this paper
• Pharmacodynamics of current and emerging treatments for cervical cancer

  2019cites this paper
• Slicing and dicing viruses: antiviral RNA interference in mammals

  2019cites this paper
• Protein-based vehicles for biomimetic RNAi delivery

  2019cites this paper
• Therapeutic startegies for human papillomavirus infection and associated cancers.

  2018cites this paper
• A review on current status of antiviral siRNA

  2018cites this paper
• Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein

  2018cites this paper
• Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.

  2018cites this paper
• Therapeutic vaccines for high-risk HPV-associated diseases

  2017cites this paper
• The Role of Human Papillomaviruses in the Aetiopathogenesis of Head and Neck Cancer in South Asia, and Approaches to Treatment

  2017cites this paper
• Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?

  2017cites this paper
• Deletion of HPV 18 E 6 and E 7 genes using dual sgRNA-directed CRISPR / Cas 9 inhibits growth of cervical cancer cells

  2017cites this paper
• Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions

  2017cites this paper
• E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines

  2015cites this paper
• Emerging drugs for the treatment of cervical cancer

  2015cites this paper
• Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives.

  2015cites this paper
• Using RNA aptamers to manipulate the functions of Human papillomaviruses (HPV)

  2015cites this paper
• Human Papillomavirus Type 16 Pseudovirions with Few Point Mutations in L1 Major Capsid Protein FG Loop Could Escape Actual or Future Vaccination for Potential Use in Gene Therapy

  2014cites this paper
• New molecular targets against cervical cancer

  2014cites this paper
• Characterization of an RNA Aptamer Against HPV-16 L1 Virus-Like Particles

  2014cites this paper
• Mémoire de fin d'étude en vue de l'obtention d'un diplôme de Master en Biologie Moléculaire et Cellulaire Option : MICROBIOLOGIE

  2014cites this paper
• IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (Review)

  2014cites this paper
• Analysis of Pathways Affected by the Viral Oncogenes in Human Papillomavirus 16-Induced Neoplastic Progression

  2013cites this paper
• Modern Molecular and Clinical Approaches to Eradicate HPVMediated Cervical Cancer

  2013cites this paper
• HPV pseudovirion production in plants

  2013cites this paper
• VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses

  2013cites this paper
• Immunotherapy for advanced or relapsed cervical cancer

  2013cites this paper
• Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cells.

  2013cites this paper
• Emerging drugs for cervical cancer

  2012cites this paper
• Knock down of p53 or its ubiquitin ligase E6AP does not affect the sensitivity of human papillomavirus-positive cervical cancer cells to cisplatin.

  2012cites this paper
• Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.

  2012cites this paper
• Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

  2012cites this paper
• Human papillomavirus 18 E6 inhibits phosphorylation of p53 expressed in HeLa cells

  2012cites this paper
• 5 Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

  2012cites this paper
• New adjuvants in evolving vaccine strategies

  2011cites this paper
• Prevalence of polyomaviruses and links with human diseases

  2011cites this paper
• Identification et caractérisation d'un domaine de transactivation dans l’hélicase E1 des papillomavirus humains

  2010cites this paper
• Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies

  2010cites this paper
• Effects of HMGB1 expression suppressed by siRNA on cell cycle and proliferation of human cervical cancer cell line HeLa

  2010cites this paper
• Virus-like particle vaccines and adjuvants: the HPV paradigm

  2009cites this paper
• Strategies for short hairpin RNA delivery in cancer gene therapy

  2009cites this paper
• Particules hpv et utilisations associées

  2009cites this paper